Quality Standards for the Management of NAFLD: Consensus Recommendations from the British Association for the Study of the Liver (BASL) and British Society of Gastroenterology (BSG) NAFLD Special Interest Group

Non-alcohol-related fatty liver disease (NAFLD) is common, affecting approximately 25% of the general population. The evidence base for the investigation and management of NAFLD is large and growing, but there is currently little practical guidance to support development of services and delivery of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The lancet. Gastroenterology & hepatology 2022-04, Vol.7 (8), p.755-769
Hauptverfasser: McPherson, Stuart, Armstrong, Matthew J, Cobbold, Jeremy F., Corless, Lynsey, Anstee, Quentin M, Aspinall, Richard J., Barclay, Stephen T., Brennan, Paul N, Cacciottolo, Tessa M, Goldin, Robert D, Hallsworth, Kate, Hebditch, Vanessa, Jack, Kathryn, Jarvis, Helen, Johnson, Jill, Li, Wenhao, Mansour, Dina, McCallum, Mary, Mukhopadhya, Ashis, Parker, Richard, Ross, Valerie, Rowe, Ian A, Srivastava, Ankur, Thiagarajan, Prarthana, Thompson, Alexandra I., Tomlinson, Jeremy, Tsochatzis, Emmanuel A., Yeoman, Andrew, Alazawi, William
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Non-alcohol-related fatty liver disease (NAFLD) is common, affecting approximately 25% of the general population. The evidence base for the investigation and management of NAFLD is large and growing, but there is currently little practical guidance to support development of services and delivery of care. To address this, we have produced a series of evidence-based quality standard recommendations for the management of NAFLD, with the aim of driving improvement in patient care. A multidisciplinary group of experts from the British Association for the Study of the Liver (BASL) and British Society of Gastroenterology (BSG) NAFLD Special Interest Group (SIG) produced the recommendations covering: 1. Management of people with, or at risk of, NAFLD before the gastroenterology or liver clinic; 2. Assessment and investigations in secondary care, and 3. Management in secondary care. The quality of evidence for each recommendation was evaluated by the Grading of Recommendation Assessment, Development and Evaluation (GRADE) tool. An anonymous modified Delphi voting process was conducted individually by each member of the group to assess the level of agreement with each statement. Statements were included where agreement was ≥80%. From the final list of statements, a smaller number of auditable key performance indicators (KPIs) were selected to allow services to benchmark their practice. It is hoped that services will review their practice against our recommendations and KPIs and institute service development where needed to improve the care of patients with NAFLD.
ISSN:2468-1253
DOI:10.1016/S2468-1253(22)00061-9